The steps below highlight key documents for ¶¶Òõ̽̽ Cancer Center members seeking to launch a new clinical research study. Contact the Clinical Trials Office with questions (802-656-4414, ext. 2).
Step One:
Review the Protocol Submission Form Instructions and FAQs (.PDF) to determine what level of review your study requires.
Tip: this interactive Protocol Review and Monitoring System Pathways presentation (.PPTX) presentation provides a summary of the pathways for protocol review (view in 'presentation mode' to click through the different approaches).
Step Two:
Reach out to the clinical trials office:
- For industry-sponsored trials: email Emma Armstrong, Study Activation Specialist at emma.armstrong@uvmhealth.org.
- For investigator-initiated trials: for support with protocol and/or budget review email Tracy Smith, Ph.D. Protocol Writer and Activation Specialist at tracy.smith@med.uvm.edu.
Step Three:
If required, complete the First Stage Review Protocol Submission Form (.PDF) for the Transdisciplinary Team (TDT) first stage study review.
- For investigators: See a the directory of transdisciplinary teams and leaders.
- For Transdisciplinary Team Leaders: access the TDT New Protocol Review (.PDF)
Step Four:
If required, complete the Investigator-Initiated Trial Treatment Protocol Template (.DOC)
- Learn more about the Protocol Review and Monitoring Committee.
- Learn more about Clinical Trials services for ¶¶Òõ̽̽ Cancer Center members.
